Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gambogic acid 20172'

Search results for: 'gambogic acid 20172'

Items 21-30 of 44

Page
per page
  1. AH 7614
    B7792 AH 7614
     1 Citation
    Target: Free Fatty Acid Receptors
    Summary: FFA4/GPR120 antagonist
      ≥35.1 mg/mL
  2. Ranitidine
    B1564 Ranitidine
    Target: Histamine H2 Receptors
    Summary: Histamine H2-receptor antagonist
      ≥17.54 mg/mL
  3. Allopurinol
    A8360 Allopurinol
    Target: Xanthine oxidoreductases
    Summary: Xanthine oxidase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.15 mg/mL
  4. Taxifolin
    N1842 Taxifolin
    Target: AdipoR2|Opioid receptors
      insoluble in H2O; ≥13.8 mg/mL
  5. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  6. I-CBP 112
    A4490 I-CBP 112
    Target: CREBBP|EP300
    Summary: CBP/EP300 bromodomain inhibitor
      ≥49.6 mg/mL
  7. NPPB
    B6367 NPPB
    Target: Calcium-activated chloride channels (CaCC)|GPR35
    Summary: inhibitor of chloride channel
      insoluble in EtOH; insoluble in H2O; ≥11.05 mg/mL
  8. Adapalene
    A1267 Adapalene
    Target: RARs
    Summary: RARβ and RARγ agonist
      insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL
  9. Ki16425
    A1987 Ki16425
     4 Citation
    Target: LPA Receptors
    Summary: LPA receptor antagonist
      ≥23.75 mg/mL
  10. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer
      ≥23.7 mg/mL

Items 21-30 of 44

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 39item
  2. Natural Products 3item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Proteasome 1 item
  2. Histone Deacetylases (HDACs) 4item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. Farnesoid X receptors (FXRs) 1 item
  6. LPA Receptors 2item
  7. DOT1L 1 item
  8. Nrf2 1 item
  9. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  10. Neuraminidases (NA) 1 item
  11. RARs 4item
  12. FAK 3item
  13. CREBBP 1 item
  14. EP300 1 item
  15. Pyk2 3item
  16. Calcium ionophores 1 item
  17. Insulin and Insulin-like Receptors 1 item
  18. AdipoR2 1 item
  19. Fatty-acid-binding proteins (FABPs) 1 item
  20. Free Fatty Acid Receptors 2item
  21. Farnesyl Diphosphate Synthases 1 item
  22. Calcium-activated chloride channels (CaCC) 1 item
  23. GPR35 1 item
  24. NPY Receptors 1 item
  25. RAR/RXR 1 item
  26. Opioid receptors 1 item
  27. Histamine H2 Receptors 1 item
  28. TRP Channel 1 item
  29. Xanthine oxidoreductases 1 item
  30. fibrinolysis 1 item
  31. GPR40 1 item
  32. PPAR 1 item
  33. HCV polymerase 1 item
  34. FAAH 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 1 item
  4. Brain Injuries Studies 1 item
  5. Breast Cancer 7item
  6. Cancer 22item
  7. Colon Cancer 2item
  8. Colorectal Cancer 3item
  9. Epilepsy 1 item
  10. Glioblastoma 1 item
  11. Glioma 2item
  12. Hepatitis C 1 item
  13. Hepatocellular Carcinoma 3item
  14. HIV Infections 2item
  15. Inflammation 1 item
  16. Inflammatory Diseases 1 item
  17. Influenza 1 item
  18. Lymphoma 1 item
  19. Melanoma 1 item
  20. Mixed Lineage Leukemia 1 item
  21. Multiple Myeloma 1 item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 1 item
  24. Ovarian Cancer 1 item
  25. Pain Relief 1 item
  26. Pancreatic Cancer 7item
  27. Prostate Cancer 4item
  28. Renal Cancer 1 item
  29. Renal Cell Carcinoma 2item
  30. Type 2 Diabetes 5item